The novel coronavirus (CoV) disease 2019 (COVID-19), which first appeared in Wuhan, China, in December 2019, spreads efficiently from person to person. After it had reached over 100 countries, on 11 March 2020 the WHO declared it a pandemic [1]. COVID-19 is caused by SARS-CoV-2, and by 9 June 2020
1. Mucolytic activity: N acetylcysteine has been used as a mucolytic agent in patients with pulmonary disease such as cystic fibrosis as well as chronic bronchitis and bronchiectasis for decades. It is usually delivered topically via a nebulizer or air supply solution. Studies have demonstrated benefits of pets mucolytic properties
The novel coronavirus (CoV) disease 2019 (COVID-19), which first appeared in Wuhan, China, in December 2019, spreads efficiently from person to person. After it had
1. Mucolytic activity: N acetylcysteine has been used as a mucolytic agent in patients with pulmonary disease such as cystic fibrosis as well as chronic